Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial. Hepatology. 2018 02; 67(2):549-559.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Benzamides
Elasticity Imaging Techniques
Female
Humans
Imidazoles
Liver Cirrhosis
Male
MAP Kinase Kinase Kinase 5
Middle Aged
Non-alcoholic Fatty Liver Disease
Protein Kinase Inhibitors
Pyridines